CP-778875

DB19211InvestigationalSmall molecule

CP-778875 is under investigation in clinical trial NCT00326326 (Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.).

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha
Curator reviewed
Formula / weight: C₂₃H₂₃NO₄S₂ · 441.56 g/mol (avg)
Also known as: 5-(((4-((4-ETHYLBENZYL)THIO)PHENYL)AMINO)SULFONYL)-2-METHYLBENZOIC ACID · Benzoic acid, 5-(((4-(((4-ethylphenyl)methyl)thio)phenyl)amino)sulfonyl)-2-methyl-
Code names: CP-778,875

Resolves to

Compound

UNII2MUX3DX6TRCAS866355-28-4

Structure

InChIKeyVRAPCAZHERPDQO-UHFFFAOYSA-NSMILESCCC1=CC=C(CSC2=CC=C(NS(=O)(=O)C3=CC=C(C)C(=C3)C(O)=O)C=C2)C=C1

Targets

Q07869PPARA

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with CP-778875, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account